IHL
Click for more information
0.00% 4.1¢ incannex healthcare limited

News: IHL Incannex Healthcare Receives IRB Approval For Reposa Phase 2/3 Clinical Trial Protocol

  1. Hot News
    186,775 Posts.
    lightbulb Created with Sketch. 2746
    clock Created with Sketch.
    17/01/24
    22:15
    Post #: 71932156

    Jan 17 (Reuters) - Incannex Healthcare Inc IQI0y.F :

    • INCANNEX HEALTHCARE:RECEIVES IRB APPROVAL FOR REPOSA PHASE 2/3 CLINICAL TRIAL PROTOCOL TO ASSESS IHL-42X DRUG IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA

    (([email protected];))

    Likes Created with Sketch. 30  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply
 

Featured News

BPH BPH Energy wraps up Q1 with $6.6M in cash but Canberra still stalling shareholders on PEP-11
right-arrow Created with Sketch.
LU7 Lithium Universe visits China's Jiangsu Li-Carb facility to shore up design specifics
right-arrow Created with Sketch.
BPH BPH Energy renews NT Bonaparte Basin permit
right-arrow Created with Sketch.
LU7 Lithium Universe successfully locks in $3.65M to advance North American play
right-arrow Created with Sketch.
LU7 Lithium Universe ends the quarter on the charge for Quebec Refinery development
right-arrow Created with Sketch.
BB1 BlinkLab partnership with US-based Turning Pointe raises smart tech hopes for autism kids
right-arrow Created with Sketch.

Top Stories

watchlist Created with Sketch. Add IHL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.